Liwei Han*, Huanyu Jia, Hua Wang
Pain Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China
Objective: To observe the clinical effect of zoladex combined with Arimidex and chemotherapy in the treatment of premenopausal recurrent metastatic breast cancer, and summarize scientific nursing program to explore the nursing effect.
Methods: This study was performed on 180 patients with premenopausal recurrent metastatic breast cancer who were treated in our hospital. The patients were given zoladex combined with Arimidex and chemotherapy, also high-quality nursing was provided. The treatment effect of the patients was counted and the quality of life before and after the nursing was observed.
Results: The total effective rate of CR+PR+SD≥ in half a year was 77.78% by the combination of zoladex and Arimidex combined with chemotherapy. Meanwhile, after the scientific quality nursing service measures were taken, the patients’ quality of life was significantly higher than that before treatment, p<0.05, with statistical significance.
Conclusion: The combination of zoladex and Arimidex combined with chemotherapy can achieve good therapeutic results among patients with premenopausal recurrent metastatic breast cancer.
zoladex, Arimidex, combined chemotherapy, premenopausal recurrent metastatic breast cancer, nursing program.
10.19193/0393-6384_2021_4_395